Dennis Gilbert, Joseph Shaw, Thomas Watkins, Frank Douglas, Paul Lucas, Neil M. Reid, Michael Mueller, Arden Bement, Jr., and Randall Murch | GenomeWeb

Dennis Gilbert has become CSO and vice president for research of Applied Biosystems, as well as vice president of Applera, the company said in an SEC filing this week. He joined Applera in 1994 as a research scientist and was most recently ABI’s vice president for advanced research and technology.


Joseph Shaw has been appointed as CEO and member of the board of directors of OpGen. Shaw comes to the position from a presidency at Bank On a Cure, and from AusAmerican Group, where he also served as president.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.